{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:40:51Z","timestamp":1790192451264,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-13040-9","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T08:22:16Z","timestamp":1740990136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Long-term outcomes and survival rates of renal cell carcinoma patients in Erbil, Iraq: a follow-up study"],"prefix":"10.1186","volume":"25","author":[{"given":"Fahmi Mohammed","family":"Salih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami Saleem","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hawro Taha","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karez Sarbast","family":"Namiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana Rizgar Mohammed","family":"Ameen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kakil Ibrahim","family":"Rasul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherzad Ali","family":"Ismael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"issue":"1","key":"13040_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","volume":"70","author":"H Moch","year":"2016","unstructured":"Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of tumours of the urinary system and male genital organs\u2014part A: renal, penile, and testicular tumours. Eur Urol. 2016;70(1):93\u2013105.","journal-title":"Eur Urol"},{"issue":"4","key":"13040_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","volume":"3","author":"C Fitzmaurice","year":"2017","unstructured":"Fitzmaurice C, Allen C, Barber RM, et al. For global burden of Disease Cancer collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524\u201348.","journal-title":"JAMA Oncol"},{"key":"13040_CR3","unstructured":"Board PC. Genetics of Kidney Cancer (Renal Cell Cancer) (PDQ). In: PDQ Cancer Information Summaries [Internet]. National Cancer Institute (US); 1 Nov 2013."},{"issue":"3","key":"13040_CR4","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.eururo.2014.10.002","volume":"67","author":"A Znaor","year":"2015","unstructured":"Znaor A, Lortet-Tieulent J, Laversanne M, et al. International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol. 2015;67(3):519\u201330.","journal-title":"Eur Urol"},{"issue":"5","key":"13040_CR5","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1053\/j.seminoncol.2016.09.001","volume":"43","author":"LS Schmidt","year":"2016","unstructured":"Schmidt LS, Linehan WM. Genetic predisposition to kidney cancer. Semin Oncol. 2016;43(5):566\u201374.","journal-title":"Semin Oncol"},{"issue":"1","key":"13040_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"13040_CR7","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.ucl.2008.07.005","volume":"35","author":"GJ Decastro","year":"2008","unstructured":"Decastro GJ, McKiernan JM. Epidemiology, clinical staging, and presentation of renal cell carcinoma. Urol Clin North Am. 2008;35(4):581\u201392. vi.","journal-title":"Urol Clin North Am"},{"key":"13040_CR8","doi-asserted-by":"crossref","unstructured":"Al-Bayati O, Hasan A, Pruthi D, Kaushik D, Liss MA. Systematic review of modifiable risk factors for kidney cancer. InUrologic Oncology: Seminars and Original Investigations 2019 Jun 1 (Vol. 37, No. 6, pp. 359\u2013371). Elsevier.","DOI":"10.1016\/j.urolonc.2018.12.008"},{"issue":"7","key":"13040_CR9","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0301-5629(99)00070-8","volume":"25","author":"S Mihara","year":"1999","unstructured":"Mihara S, Kuroda K, Yoshioka R, et al. Early detection of renal cell carcinoma by ultrasonographic screening\u2014based on the results of 13 years screening in Japan. Ultrasound Med Biol. 1999;25(7):1033\u20139.","journal-title":"Ultrasound Med Biol"},{"key":"13040_CR10","unstructured":"Anderson D, Tretiakova M, Sarcomatoid. PathologyOutlines.com website. https:\/\/www.pathologyoutlines.com\/topic\/kidneytumormalignantrccsarcoma.html. Accessed November 16th, 2023."},{"key":"13040_CR11","unstructured":"Siegel R et al. CA Cancer J Clin. 2020;70:7\u201330 Surveillance, Epidemiology and End Results (SEER) Program, http:\/\/seer.cancer.gov [accessed in 2020]."},{"key":"13040_CR12","unstructured":"National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program, 2013\u20132016. Kidney and Renal Pelvis Cancer - Cancer Stat Facts: Kidney and Renal Pelvis Cancer Expand All Collapse All Statistics At a Glance Estimated New Cases \u2026 https:\/\/seer.cancer.gov\/statfacts\/html\/kidrp.html"},{"key":"13040_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00345-010-0540-8","volume":"28","author":"A Volpe","year":"2010","unstructured":"Volpe A, Patard JJ. Prognostic factors in renal cell carcinoma. World J Urol. 2010;28:319\u201327. https:\/\/doi.org\/10.1007\/s00345-010-0540-8.","journal-title":"World J Urol"},{"key":"13040_CR14","unstructured":"Cancer Incidence in Five Continents Volume X - CI5X Tables: indices of data quality [Internet] World Health Organization; 2016. [Accessed Feb. 6, 2018]. pp. 1\u20135."},{"key":"13040_CR15","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1016\/j.ejca.2008.06.017","volume":"44","author":"KT Eriksen","year":"2008","unstructured":"Eriksen KT, Petersen A, Poulsen AH, et al. Social inequality and incidence of and survival from cancers of the kidney and urinary bladder in a population-based study in Denmark, 1994\u20132003. Eur J Cancer. 2008;44:2030\u201342.","journal-title":"Eur J Cancer"},{"key":"13040_CR16","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.juro.2012.01.121","volume":"187","author":"AR Patel","year":"2012","unstructured":"Patel AR, Prasad SM, Shih Y-CT, et al. The association of the human development index with global kidney cancer incidence and mortality. J Urol. 2012;187:1978\u201383.","journal-title":"J Urol"},{"key":"13040_CR17","unstructured":"Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA. SEER cancer statistics review, 1975\u20132016. Based on November 2018 SEER data submission, posted to the SEER website. 2019."},{"key":"13040_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12894-024-01441-8","volume":"24","author":"L Guo","year":"2024","unstructured":"Guo L, An T, Huang Z, et al. A network meta-analysis evaluating the efficacy and safety of adjuvant therapy after nephrectomy in renal cell carcinoma. BMC Urol. 2024;24:55. https:\/\/doi.org\/10.1186\/s12894-024-01441-8.","journal-title":"BMC Urol"},{"key":"13040_CR19","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s11864-023-01161-5","volume":"24","author":"YW Chen","year":"2023","unstructured":"Chen YW, Wang L, Panian J, et al. Treatment Landscape of Renal Cell Carcinoma. Curr Treat Options Oncol. 2023;24:1889\u2013916. https:\/\/doi.org\/10.1007\/s11864-023-01161-5.","journal-title":"Curr Treat Options Oncol"},{"key":"13040_CR20","doi-asserted-by":"crossref","unstructured":"Daugherty M, Bratslavsky G. Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (\u2264\u20094\u00a0cm): an analysis of the SEER database. InUrologic Oncology: Seminars and Original Investigations 2014 Jul 1 (Vol. 32, No. 5, pp. 549\u2013554). Elsevier.","DOI":"10.1016\/j.urolonc.2013.11.009"},{"key":"13040_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00428-016-2031-9","volume":"470","author":"L Wang","year":"2017","unstructured":"Wang L, Hughes I, Snarskis C, Alvarez H, Feng J, Gupta GN, Picken MM. Tumor enucleation specimens of small renal tumors more frequently have a positive surgical margin than partial nephrectomy specimens, but this is not associated with local tumor recurrence. Virchows Arch. 2017;470:55\u201361.","journal-title":"Virchows Arch"},{"key":"13040_CR22","doi-asserted-by":"crossref","unstructured":"Zequi St\u00eanio, de C\u00e1ssio et al. Predictors of survival outcomes in Non-metastatic Renal Cell Carcinoma in Latin America and Spain: a multicentric analysis. Kidney Cancer. 1 Jan 2019;3(4):253\u201361.","DOI":"10.3233\/KCA-190068"},{"key":"13040_CR23","doi-asserted-by":"publisher","first-page":"6633","DOI":"10.1007\/s13277-014-1862-8","volume":"35","author":"Y Xu","year":"2014","unstructured":"Xu Y, Qi Y, Zhang J, Lu Y, Song J, Dong B, Kong W, Xue W, Huang Y. The impact of smoking on survival in renal cell carcinoma: a systematic review and meta-analysis. Tumor Biology. 2014;35:6633\u201340.","journal-title":"Tumor Biology"},{"issue":"1","key":"13040_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1634\/theoncologist.2012-0335","volume":"19","author":"D Keizman","year":"2014","unstructured":"Keizman D, Gottfried M, Ish-Shalom M, Maimon N, Peer A, Neumann A, Hammers H, Eisenberger MA, Sinibaldi V, Pili R, Hayat H. Active smoking may negatively affect response rate, progression-free survival, and overall survival of patients with metastatic renal cell carcinoma treated with sunitinib. Oncologist. 2014;19(1):51\u201360.","journal-title":"Oncologist"},{"key":"13040_CR25","doi-asserted-by":"crossref","unstructured":"Baral A, Cranford HM, Sharma J, Pinheiro PS. The prognostic role of cigarette smoking in kidney Cancer survival. Cancer Med. 2023 May 18.","DOI":"10.1002\/cam4.6104"},{"issue":"1","key":"13040_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/0284186X.2021.2005255","volume":"61","author":"TA Horsb\u00f8l","year":"2022","unstructured":"Horsb\u00f8l TA, Dalton SO, Christensen J, Petersen AC, Azawi N, Donskov F, Holm ML, N\u00f8rgaard M, Lund L. Impact of comorbidity on renal cell carcinoma prognosis: a nationwide cohort study. Acta Oncol. 2022;61(1):58\u201363.","journal-title":"Acta Oncol"},{"key":"13040_CR27","doi-asserted-by":"crossref","unstructured":"Rampersaud EN, Klatte T, Bass G, Patard JJ, Bensaleh K, B\u00f6hm M, Allhoff EP, Cindolo L, De La Taille A, Mejean A, Soulie M. The effect of gender and age on kidney cancer survival: younger age is an independent prognostic factor in women with renal cell carcinoma. InUrologic Oncology: Seminars and Original Investigations 2014 Jan 1 (Vol. 32, No. 1, pp. 30-e9). Elsevier.","DOI":"10.1016\/j.urolonc.2012.10.012"},{"issue":"18","key":"13040_CR28","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.3390\/cancers13184588","volume":"13","author":"AJ Peired","year":"2021","unstructured":"Peired AJ, Campi R, Angelotti ML, Antonelli G, Conte C, Lazzeri E, Becherucci F, Calistri L, Serni S, Romagnani P. Sex and gender differences in kidney cancer: clinical and experimental evidence. Cancers. 2021;13(18):4588.","journal-title":"Cancers"},{"issue":"7","key":"13040_CR29","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1158\/1055-9965.EPI-17-0092","volume":"26","author":"KD Blake","year":"2017","unstructured":"Blake KD, Moss JL, Gaysynsky A, Srinivasan S, Croyle RT. Making the case for investment in rural cancer control: an analysis of rural cancer incidence, mortality, and funding trends. Cancer Epidemiol Biomarkers Prev. 2017;26(7):992\u20137.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"13040_CR30","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.juro.2017.04.100","volume":"198","author":"S Campbell","year":"2017","unstructured":"Campbell S, Uzzo RG, Allaf ME, Bass EB, Cadeddu JA, Chang A, Clark PE, Davis BJ, Derweesh IH, Giambarresi L, Gervais DA, Hu SL, Lane BR, Leibovich BC, Pierorazio PM. Renal Mass and localized renal Cancer: AUA Guideline. J Urol. 2017;198(3):520\u20139.","journal-title":"J Urol"},{"issue":"3","key":"13040_CR31","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.urology.2009.11.087","volume":"76","author":"CJ Weight","year":"2010","unstructured":"Weight CJ, Larson BT, Gao T, Campbell SC, Lane BR, Kaouk JH, Gill IS, Klein EA, Fergany AF. Elective partial nephrectomy in patients with clinical T1b renal tumors is associated with improved overall survival. Urology. 2010;76(3):631\u20137.","journal-title":"Urology"},{"key":"13040_CR32","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.juro.2007.09.077","volume":"179","author":"RH Thompson","year":"2008","unstructured":"Thompson RH, Boorjian SA, Lohse CM, et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol. 2008;179:468\u201371. discussion 472\u2009\u2013\u2009463.","journal-title":"J Urol"},{"issue":"6","key":"13040_CR33","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/bju.12883","volume":"115","author":"SA Yap","year":"2015","unstructured":"Yap SA, Finelli A, Urbach DR, Tomlinson GA, Alibhai SM. Partial nephrectomy for the treatment of renal cell carcinoma (RCC) and the risk of end-stage renal disease (ESRD). BJU Int. 2015;115(6):897\u2013906.","journal-title":"BJU Int"},{"key":"13040_CR34","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1200\/JCO.2002.20.1.289","volume":"20","author":"RJ Motzer","year":"2002","unstructured":"Motzer RJ, Bacik J, Murphy BA, et al. Interferon-Alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. J Clin Oncol. 2002;20:289\u201396.","journal-title":"J Clin Oncol"},{"key":"13040_CR35","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.1200\/JCO.2008.21.4809","volume":"27","author":"DY Heng","year":"2009","unstructured":"Heng DY, Xie W, Regan MM, et al. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study. J Clin Oncol. 2009;27:5794\u20139.","journal-title":"J Clin Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13040-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-13040-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13040-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T11:51:48Z","timestamp":1741348308000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-13040-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13040"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-13040-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]},"assertion":[{"value":"4 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol adhered to rigorous ethical standards and received full approval from the Kurdistan Board of Medical Specialties Research Ethics Committee, located in Erbil, Iraq on 23rd January 2024. The research protocol also aligned with the ethical principles outlined in the Declaration of Helsinki for Medical Research. As our study involved a retrospective analysis of recorded data between January 2017 to December 2020, informed consent was not obtained from individual participants. This approach was in accordance with the guidelines of Kurdistan Board of Medical Specialties Research Ethics Committee, which waived the requirement for informed consent due to the nature of the study design and the use of anonymized data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"384"}}